PVI
ALIM

Pura Vida Investments’s Alimera Sciences ALIM Stock Holding History

Pura Vida Investments’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-83,333
Closed -$2.76M – 91
2015
Q3 		$2.76M Buy
+83,333
New +$4.69M 1.58% 26
2015
Q1 		– Sell
-13,667
Closed -$1.14M – 88
2014
Q4 		$1.14M Buy
+13,667
New +$1.11M 0.42% 57

Other funds holding ALIM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SM
Scale Management Foster City, California $359M AUM
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Pura Vida Investments's ALIM Position: Q1 2016 in Review

Pura Vida Investments sold out of Alimera Sciences (ALIM) in Q1 2016, closing a stake of 8,640 shares — an estimated $314K sold.

Pura Vida Investments first reported a position in ALIM in Q4 2014 and held it in 5 quarters. The position peaked at $6M in Q2 2015. 54 funds tracked by Wall St. Rank hold ALIM as of Q1 2016.

  • Pura Vida Investments reported no remaining Alimera Sciences position as of Q1 2016 after selling out during the quarter.
  • Pura Vida Investments sold 8,640 Alimera Sciences shares in Q1 2016, an estimated $314K.
  • Pura Vida Investments first reported a position in Alimera Sciences in Q4 2014 and held it in 5 quarters.
  • Pura Vida Investments's Alimera Sciences position peaked at $6M in Q2 2015.
  • 54 funds tracked by Wall St. Rank held Alimera Sciences as of Q1 2016.

Based on Pura Vida Investments's 13F filing for Q1 2016, filed 16 May 2016.